Clinical experience of TB in patients treated with anti-TNF-α

被引:0
作者
Arenas-Miras, M. [1 ]
Sanchez-martinez, F. [1 ]
Jove-Caballe, N. [1 ]
Villar-Garcia, J. [1 ]
Lopez-Montesinos, I. [1 ]
Grau, S. [2 ]
Carballo, N. [2 ]
Knobel-Freud, H. [1 ]
Horcajada, J. P. [1 ]
机构
[1] Hosp Mar, Infect Dis Dept, Infect Pathol & Antimicrobials Res Grp IPAR, Inst Hosp Mar Invest Med IMIM, Barcelona, Spain
[2] Hosp Mar, Pharm Dept, Infect Pathol & Antimicrobials Res Grp IPAR, Inst Hosp Mar Invest Med IMIM, Barcelona, Spain
关键词
TUBERCULOSIS; THERAPY; PREVENTION; RISK;
D O I
10.5588/ijtld.21.0166
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:866 / 868
页数:3
相关论文
共 15 条
  • [1] Prednisolone Treatment Affects the Performance of the QuantiFERON Gold In-Tube Test and the Tuberculin Skin Test in Patients with Autoimmune Disorders Screened for Latent Tuberculosis Infection
    Belard, Erika
    Semb, Synne
    Ruhwald, Morten
    Werlinrud, Anne Marie
    Soborg, Bolette
    Jensen, Frank Krieger
    Thomsen, Henrik
    Brylov, Annette
    Hetland, Merete Lund
    Nordgaard-Lassen, Inge
    Ravn, Pernille
    [J]. INFLAMMATORY BOWEL DISEASES, 2011, 17 (11) : 2340 - 2349
  • [2] Disseminated tuberculosis complicated by immune reconstitution inflammatory syndrome under anti-TNF treatment
    Benchoukroun, Segolene
    Gaillard, Sacha
    Vermersch-Langlin, Annie
    Deregnaucourt, Delphine
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2020, 30 (03) : 322 - 323
  • [3] Latent tuberculosis infection detection and active tuberculosis prevention in patients receiving anti-TNF therapy: an Italian nationwide survey
    Cantini, Fabrizio
    Lubrano, Ennio
    Marchesoni, Antonio
    Mathieu, Alessandro
    Olivieri, Ignazio
    Salvarani, Carlo
    Scarpa, Raffaele
    Spadaro, Antonio
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2016, 19 (08) : 799 - 805
  • [4] Risk of tuberculosis comparison in new users of antitumour necrosis factor-α and with existing disease-modifying antirheumatic drug therapy
    Chan, M. -J.
    Wen, Y. -H.
    Huang, Y. -B.
    Chuang, H. -Y.
    Tain, Y. -L.
    Wang, Y. -C. Lily
    Hsu, C. -N.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2018, 43 (02) : 256 - 264
  • [5] Characterization of QuantiFERON-TB-Plus results in latent tuberculosis infected patients with or without immune-mediated inflammatory diseases
    Chiacchio, Teresa
    Petruccili, Elisa
    Vanini, Valentina
    Cuzzi, Gilda
    Massafra, Umberto
    Baldi, Gianpiero
    Navarra, Assunta
    Scrivo, Rossana
    Mastroianni, Claudio
    Sauzullo, Ilaria
    Esposito, Carmela
    Palmieri, Fabrizio
    Cantini, Fabrizio
    Goletti, Delia
    [J]. JOURNAL OF INFECTION, 2019, 79 (01) : 15 - 23
  • [6] Long-term follow-up of patients with tuberculosis as a complication of tumour necrosis factor (TNF)-α antagonist therapy:: safe re-initiation of TNF-α blockers after appropriate anti-tuberculous treatment
    Denis, B.
    Lefort, A.
    Flipo, R. M.
    Tubach, F.
    Lemann, M.
    Ravaud, P.
    Salmon, D.
    Mariette, X.
    Lortholary, O.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 (02) : 183 - 186
  • [7] Tuberculosis and Biologic Therapies Anti-Tumor Necrosis Factor-α and Beyond
    Godfrey, Mark S.
    Friedman, Lloyd N.
    [J]. CLINICS IN CHEST MEDICINE, 2019, 40 (04) : 721 - +
  • [8] Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugs
    Goletti, Delia
    Petrone, Linda
    Ippolito, Giuseppe
    Niccoli, Laura
    Nannini, Carlotta
    Cantini, Fabrizio
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2018, 16 (06) : 501 - 512
  • [9] British Thoracic Society (BTS) recommendations for assessing risk and managing tuberculosis in patients due to start anti-TNF-α treatments
    Ledingham, J
    Wilkinson, C
    Deighton, C
    [J]. RHEUMATOLOGY, 2005, 44 (10) : 1205 - 1206
  • [10] Prevention of Anti-Tumor Necrosis Factor-Associated Tuberculosis: A 10-Year Longitudinal Cohort Study
    Munoz, Laura
    Casas, Susana
    Juanola, Xavier
    Bordas, Xavier
    Martinez, Concepcion
    Santin, Miguel
    [J]. CLINICAL INFECTIOUS DISEASES, 2015, 60 (03) : 349 - 356